Patents by Inventor Karsten PUTZBACH

Karsten PUTZBACH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester
    Patent number: 12653807
    Abstract: Drug products in the form of modified release formulations comprising the drug substance (?)-(3aR,4S,7aR)-4-Hydroxy-4m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester (AFQ056), as well as processes for making such drug products are provided. The drug products are useful in treating patients with Parkinson's disease and exhibiting L-dopa induced dyskinesia.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: June 16, 2026
    Assignee: NOVARTIS AG
    Inventors: Bruno Galli, Jean-Marie Glantzmann, Arnaud Grandeury, Klaus-Peter Moll, Martin Mueller-Zsigmondy, Karsten Putzbach, Dirk Spickermann, Hubert Thoma, Mike Ufer
  • MODIFIED RELEASE FORMULATION
    Publication number: 20230355582
    Abstract: Drug products in the form of modified release formulations comprising the drug substance (-)-(3aR,45,7aR)-4-Hydroxy-4m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester (AFQ056), as well as processes for making such drug products are provided. The drug products are useful in treating patients with Parkinson's disease and exhibiting L-dopa induced dyskinesia.
    Type: Application
    Filed: July 20, 2023
    Publication date: November 9, 2023
    Applicant: NOVARTIS AG
    Inventors: Bruno GALLI, Jean-Marie GLANTZMANN, Arnaud GRANDEURY, Klaus-Peter MOLL, Martin MUELLER-ZSIGMONDY, Karsten PUTZBACH, Dirk SPICKERMANN, Hubert THOMA, Mike UFER
  • MODIFIED RELEASE FORMULATION
    Publication number: 20210069150
    Abstract: Drug products in the form of modified release formulations comprising the drug substance (?)-(3aR,4S,7aR)-4-Hydroxy-4m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester (AFQ056), as well as processes for making such drug products are provided. The drug products are useful in treating patients with Parkinson's disease and exhibiting L-dopa induced dyskinesia.
    Type: Application
    Filed: June 10, 2020
    Publication date: March 11, 2021
    Inventors: Bruno GALLI, Jean-Marie GLANTZMANN, Arnaud GRANDEURY, Klaus-Peter MOLL, Martin MUELLER- ZSIGMONDY, Karsten PUTZBACH, Dirk SPICKERMANN, Hubert THOMA, Mike UFER
  • MODIFIED RELEASE FORMULATION
    Publication number: 20160128979
    Abstract: Drug products in the form of modified release formulations comprising the drug substance (-)-(3aR,4S,7aR)-4-Hydroxy-4m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester (AFQ056), as well as processes for making such drug products are provided. The drug products are useful in treating patients with Parkinson's disease and exhibiting L-dopa induced dyskinesia.
    Type: Application
    Filed: June 11, 2014
    Publication date: May 12, 2016
    Inventors: Bruno GALLI, Hubert THOMA, Arnaud GRANDEURY, Dirk SPICKERMANN, Karsten PUTZBACH, Klaus-Peter MOLL, Mike UFER, Jean-Marie GLANTZMANN, Martin MUELLER-ZSIGMONDY